AstraZeneca offers a rare, secular growth profile in biopharma, underpinned by a diversified commercial asset base and layered patent expirations. AZN faces a minor patent cliff, with most key ...
Phase III trial involved 594 patients across 20 countries Ceralasertib-Imfinzi combo showed no new safety concerns AstraZeneca shares fall 1% after trial results Dec 22 (Reuters) - AstraZeneca (AZN.L) ...
Less than two years after buying Chinese biotech Gracell for its cell therapy platform, AstraZeneca has reported encouraging clinical results with the lead CAR-T from the deal, GC012F (now AZD0120), ...
The pharmaceutical company AstraZeneca can move forward with an addition to one of the buildings on its Frederick campus, after getting approval from the city of Frederick’s Planning Commission. The ...
Swedish archaeologists recently uncovered remnants of a forgotten 16th-century city beneath modern-day Gothenburg. The excavation was conducted by Arkeologerna, a Swedish archaeological consultancy, ...
Details are trickling in about the new manufacturing facility pharmaceutical giant AstraZeneca is building in Albemarle County.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results